Key result
Metagenomic next-generation sequencing enhanced enterovirus detection to 57% vs 42% for qRT-PCR (p=0.013), and VirScan with ELISA increased CSF detection to 92% vs 46% (p=0.023).
Why the study?
During a 2016 pediatric brainstem encephalitis outbreak caused by enterovirus A71, conventional testing rarely identified the virus in CSF, prompting the deployment of mNGS and VirScan to enhance detection and characterization.
Do mNGS and VirScan improve the detection of enterovirus in pediatric patients with brainstem encephalitis compared to conventional qRT-PCR?
Observational
Do mNGS and VirScan improve the detection of enterovirus in pediatric patients with brainstem encephalitis compared to conventional qRT-PCR?
Absolute Event Rate: 57% vs 42%
p-value: p=0.013
mNGS and VirScan significantly improve the detection of enterovirus in the central nervous system compared to conventional qRT-PCR in pediatric encephalitis.
mNGS plus VirScan boosts EV detection in pediatric encephalitis; leaves open routine adoption pending prospective validation.
Objective In 2016, Catalonia experienced a pediatric brainstem encephalitis outbreak caused by enterovirus A71 (EV-A71). Conventional testing identified EV in the periphery but rarely in CSF. Metagenomic next-generation sequencing (mNGS) and CSF pan-viral serology (VirScan) were deployed to enhance viral detection and characterization. Methods RNA was extracted from the CSF (n = 20), plasma (n = 9), stool (n = 15), and nasopharyngeal samples (n = 16) from 10 children with brainstem encephalitis and 10 children with meningitis or encephalitis. Pathogens were identified using mNGS. Available CSF from cases (n = 12) and pediatric other neurologic disease controls (n = 54) were analyzed with VirScan with a subset (n = 9 and n = 50) validated by ELISA. Results mNGS detected EV in all samples positive by quantitative reverse transcription polymerase chain reaction (qRT-PCR) (n = 25). In qRT-PCR-negative samples (n = 35), mNGS found virus in 23% (n = 8, 3 CSF samples). Overall, mNGS enhanced EV detection from 42% (25/60) to 57% (33/60) (p-value = 0.013). VirScan and ELISA increased detection to 92% (11/12) compared with 46% (4/12) for CSF mNGS and qRT-PCR (p-value = 0.023). Phylogenetic analysis confirmed the EV-A71 strain clustered with a neurovirulent German EV-A71. A single amino acid substitution (S241P) in the EVA71 VP1 protein was exclusive to the CNS in one subject. Conclusion mNGS with VirScan significantly increased the CNS detection of EVs relative to qRT-PCR, and the latter generated an antigenic profile of the acute EV-A71 immune response. Genomic analysis confirmed the close relation of the outbreak EV-A71 and neuroinvasive German EV-A71. A S241P substitution in VP1 was found exclusively in the CSF.
No takes yet. Share an insight, caveat, or question.
Leon et al. (2020) conducted an observational in Enterovirus A71 brainstem encephalitis. Metagenomic next-generation sequencing (mNGS) and VirScan vs. Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was evaluated on Enterovirus detection rate (p=0.013). Metagenomic next-generation sequencing enhanced enterovirus detection to 57% vs 42% for qRT-PCR (p=0.013), and VirScan with ELISA increased CSF detection to 92% vs 46% (p=0.023).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: